E-LIB Suche - Ergebnisse für: Kwak, Larry W.

1

Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in R..:

Kambhampati, Swetha ; Mei, Matthew G. ; Chen, Lu...
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

2

Analysis of polyfunctionality for enhanced BAFF-R CAR T-cel..:

Dong, Zhengyuan ; Budde, L. Elizabeth ; Oh, Elizabeth...
Blood Advances. 8 (2024) 15 - p. 4066-4076 , 2024

Link: https://doi.org/10.1182/..

3

Generation of a humanized afucosylated BAFF-R antibody with..:

Dong, Zhenyuan ; Song, Joo Y. ; Thieme, Elana...
Blood Advances. 7 (2023) 6 - p. 918-932 , 2023

Link: https://doi.org/10.1182/..

4

Results from a phase I trial of pembrolizumab plus vorinost..:

Godfrey, James ; Mei, Matthew ; Chen, Lu...
Haematologica. 109 (2023) 2 - p. 533-542 , 2023

Link: https://doi.org/10.3324/..

5

Real-World Outcomes of CD19 CAR T Cell Therapy in Adult Pat..:

Kambhampati, Swetha ; Popplewell, Leslie ; Wang, Yan...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S372-S373 , 2023

Link: https://doi.org/10.1016/..

6

Cost-effectiveness of polatuzumab vedotin combined with che..:

Kambhampati, Swetha ; Saumoy, Monica ; Schneider, Yecheskel...
Blood. 140 (2022) 25 - p. 2697-2708 , 2022

Link: https://doi.org/10.1182/..

7

CD19/BAFF-R dual-targeted CAR T cells for the treatment of ..:

Wang, Xiuli ; Dong, Zhenyuan ; Awuah, Dennis...
Leukemia. 36 (2022) 4 - p. 1015-1024 , 2022

Link: https://doi.org/10.1038/..

8

Efficacy and Safety of CT-P10 Versus Rituximab in Untreated..:

Kwak, Larry W. ; Sancho, Juan-Manuel ; Cho, Seok-Goo...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 2 - p. 89-97 , 2022

Link: https://doi.org/10.1016/..

9

Avelumab (A) Plus Utomilumab (U) in Combination with RICE (..:

Nikolaenko, Liana ; Chen, Lu ; Herrera, Alex F....
Transplantation and Cellular Therapy. 27 (2021) 3 - p. S47-S48 , 2021

Link: https://doi.org/10.1016/..

10

Corrigendum to "Prime-Boost Vaccination Using Chemokine-Fus..:

Qin, Hong ; Nehete, Pramod N. ; He, Hong...
BioMed Research International. 2020 (2020) - p. 1-2 , 2020

Link: https://doi.org/10.1155/..

11

Antitumor efficacy of BAFF-R targeting CAR T cells manufact..:

Dong, Zhenyuan ; Cheng, Wesley A. ; Smith, D. Lynne...
Cancer Immunology, Immunotherapy. 69 (2020) 10 - p. 2139-2145 , 2020

Link: https://doi.org/10.1007/..

12

Long‐term overall‐ and progression‐free survival after pent..:

Khashab, Tamer ; Hagemeister, Fredrick ; Romaguera, Jorge E....
British Journal of Haematology. 185 (2019) 4 - p. 670-678 , 2019

Link: https://doi.org/10.1111/..

13

Phase 2 trial of bortezomib in combination with rituximab p..:

Romaguera, Jorge E. ; Wang, Michael ; Feng, Lei...
Cancer. 124 (2018) 12 - p. 2561-2569 , 2018

Link: https://doi.org/10.1002/..

14

Phase I study of an active immunotherapy for asymptomatic p..:

Thomas, Sheeba K. ; Cha, Soung-chul ; Smith, D. Lynne...
BMC Cancer. 18 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

15

Targeting myeloid-derived suppressor cells for cancer immun..:

Liu, Yijun ; Wei, Guowei ; Cheng, Wesley A....
Cancer Immunology, Immunotherapy. 67 (2018) 8 - p. 1181-1195 , 2018

Link: https://doi.org/10.1007/..